PFIZER INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that PFIZER INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.58B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $63.63B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $59.55B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $101.18B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $81.29B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $41.65B | Feb 23, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $50.91B | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | $91.79B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $73.64B | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | $41.65B | Feb 24, 2022 |
| FY2021 | Dec 31, 2019 | $40.91B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $40.83B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $52.55B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $52.82B | Feb 28, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Dec 31, 2013 | $51.58B | Feb 28, 2014 |
| FY2013 | Dec 31, 2012 | $54.66B | Feb 28, 2014 |
| FY2013 | Dec 31, 2011 | $61.04B | Feb 28, 2014 |
| FY2012 | Dec 31, 2010 | $65.17B | Feb 28, 2013 |
| FY2011 | Dec 31, 2009 | $49.27B | Feb 28, 2012 |
| FY2010 | Dec 31, 2008 | $48.30B | Feb 28, 2011 |
| FY2009 | Dec 31, 2007 | $48.42B | Feb 26, 2010 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.77B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.03B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.12B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $31.37B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $21.98B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $9.16B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $16.03B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $11.15B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $21.31B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $7.22B | Feb 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.79B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $14.73B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $14.77B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $13.68B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $12.70B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $11.60B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $12.73B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $12.61B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $14.80B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $14.84B | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.70B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $12.74B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $8.70B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $29.27B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $32.58B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $14.40B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $12.59B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $15.83B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $16.80B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $16.19B | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.63B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.91B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.91B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.24B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.71B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $2.23B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.05B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.98B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.96B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $1.82B | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $208.16B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $213.40B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $226.50B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $197.21B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $181.48B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $154.23B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $167.59B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $159.42B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $171.80B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $171.62B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $124.90B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $137.21B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $101.29B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $104.01B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $90.76B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $104.15B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $95.66B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $100.14B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $111.78B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $86.48B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $88.20B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $89.01B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $95.66B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $77.20B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $63.24B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $63.14B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $63.41B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $71.31B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $59.54B | Feb 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.26B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $68.53B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $67.78B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $51.38B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $49.21B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $49.56B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $48.18B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $42.93B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $55.95B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $54.45B | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $114.61B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $116.73B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $118.35B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $125.66B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $103.39B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $90.39B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $97.67B | Feb 25, 2021 |
| FY2019 | Jan 1, 2019 | $89.57B | Feb 27, 2020 |
| FY2019 | Dec 31, 2018 | $89.55B | Feb 27, 2020 |
| FY2018 | Jan 1, 2018 | $86.47B | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.14B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.04B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.85B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $416.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.94B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.79B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.12B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.14B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.34B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.60B | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $4.00B | Feb 25, 2021 |
| FY2016 | Dec 31, 2016 | $31.40B | Feb 23, 2017 |
| FY2015 | Dec 31, 2015 | $28.82B | Feb 29, 2016 |
| FY2014 | Dec 31, 2014 | $31.54B | Feb 27, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 28, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 5 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 2 | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | 1 | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | 3 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 28, 2019 |